Skip to main content
Top
Published in: Journal of Experimental & Clinical Cancer Research 1/2017

Open Access 01-12-2017 | Research

Ternary cocktail nanoparticles for sequential chemo-photodynamic therapy

Authors: Li Fan, Saisai Zhao, Qian Yang, Jiali Tan, Chaojun Song, Hong Wu

Published in: Journal of Experimental & Clinical Cancer Research | Issue 1/2017

Login to get access

Abstract

Background

Previous clinical trials have already demonstrated that combinations of two or more drugs were more effective in the cancer treatment, especially sequential photodynamic design combing with sequential chemotherapy. In our study, we propose a ternary cocktail NP delivery system based on self-decomposable NPs, which could realize synergistic chemo-photodynamic therapy through double loading chemo-drugs and multi-level programmable PDT treatment.

Methods

PS drug methylene blue (MB) was encapsulated into the center of the NPsmall, NPbig&thin, and NPbig&thick carriers through “grown-in” loading mechanism, which was released based on the drug concentration difference of the drug release environment. NPsmall, NPbig&thin, and NPbig&thick carriers have three different drug release profiles, which could realize multi-level programmable PDT treatment. At the same time, antitumor drug gemcitabine hydrochloride (GM) and Docetaxel (DTX), were chosen as the double loading chemo-drugs that absorbed onto the NPbig&thin and NPbig&thick surface, respectively. In specific, various particle configurations were used for modulating the inner MB sequential release with three pulse Tmax. Also, by adjusting the NPbig&thin and NPbig&thick configuration, the release interval lag time between absorbed GM and DTX can be successfully modulated to achieve maximized chemotherapeutic efficacy.

Results

In vitro and in vivo results demonstrated that these three pulses Tmax and the sustained release of MB could maximize the multi-level programmable PDT treatment. And the absorbed GM and DTX also have a release time lag of 12 h, which has been proved as the most effectiveness synergistic interval lag time in the cancer treatment.

Conclusion

Such a precise sequential release manner ternary cocktail NPs provided a promising platform for efficient and safe chemo-photodynamic therapy, which serves as a promising drug delivery system to cure cancer in the future.
Appendix
Available only for authorised users
Literature
1.
go back to reference Canti G, et al. Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors. Cancer Lett. 1998;125:39–44.CrossRefPubMed Canti G, et al. Antitumor efficacy of the combination of photodynamic therapy and chemotherapy in murine tumors. Cancer Lett. 1998;125:39–44.CrossRefPubMed
2.
go back to reference Kemp JA, et al. "combo" nanomedicine: co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy. Adv Drug Deliv Rev. 2016;98:3–18.CrossRefPubMed Kemp JA, et al. "combo" nanomedicine: co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy. Adv Drug Deliv Rev. 2016;98:3–18.CrossRefPubMed
3.
go back to reference Ilaria P, et al. Enhancing Photodynamyc therapy efficacy by combination therapy: dated, Current and Oncoming Strategies. Cancers. 2011;3:2597–629.CrossRef Ilaria P, et al. Enhancing Photodynamyc therapy efficacy by combination therapy: dated, Current and Oncoming Strategies. Cancers. 2011;3:2597–629.CrossRef
4.
go back to reference Bernadette BV, et al. Metaphors in nanomedicine: the case of targeted drug delivery. NanoEthics. 2014;8:1–17.CrossRef Bernadette BV, et al. Metaphors in nanomedicine: the case of targeted drug delivery. NanoEthics. 2014;8:1–17.CrossRef
5.
go back to reference A John B, et al. Relapse after allogeneic stem cell transplantation. Expert Rev Hematol. 2010;3:429–41.CrossRef A John B, et al. Relapse after allogeneic stem cell transplantation. Expert Rev Hematol. 2010;3:429–41.CrossRef
6.
go back to reference Reema S, et al. Pharmacological drug delivery strategies for improved therapeutic effects: recent advances. Curr Pharm Des. 2016;22:1506–20.CrossRef Reema S, et al. Pharmacological drug delivery strategies for improved therapeutic effects: recent advances. Curr Pharm Des. 2016;22:1506–20.CrossRef
7.
go back to reference Hu Q, et al. Recent advances of cocktail chemotherapy by combination drug delivery systems. Adv Drug Deliv Rev. 2016;98:19–34.CrossRefPubMed Hu Q, et al. Recent advances of cocktail chemotherapy by combination drug delivery systems. Adv Drug Deliv Rev. 2016;98:19–34.CrossRefPubMed
8.
go back to reference Hu CM, et al. Nanoparticle-assisted combination therapies for effective cancer treatment. Ther Deliv. 2010;1:323–34.CrossRefPubMed Hu CM, et al. Nanoparticle-assisted combination therapies for effective cancer treatment. Ther Deliv. 2010;1:323–34.CrossRefPubMed
9.
go back to reference Anajafi T, et al. Acridine Orange conjugated Polymersomes for simultaneous nuclear delivery of gemcitabine and doxorubicin to pancreatic cancer cells. Bioconjug Chem. 2016;27:762–71.CrossRefPubMed Anajafi T, et al. Acridine Orange conjugated Polymersomes for simultaneous nuclear delivery of gemcitabine and doxorubicin to pancreatic cancer cells. Bioconjug Chem. 2016;27:762–71.CrossRefPubMed
10.
go back to reference Lammers T, et al. Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers. Biomaterials. 2009;30:3466–75.CrossRefPubMed Lammers T, et al. Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers. Biomaterials. 2009;30:3466–75.CrossRefPubMed
11.
go back to reference Liu J, et al. Ring-opening polymerization of prodrugs: a versatile approach to prepare well-defined drug-loaded nanoparticles. Angew Chem Int Ed Engl. 2015;54:1002–6.CrossRefPubMed Liu J, et al. Ring-opening polymerization of prodrugs: a versatile approach to prepare well-defined drug-loaded nanoparticles. Angew Chem Int Ed Engl. 2015;54:1002–6.CrossRefPubMed
12.
go back to reference Greco F, Vicent MJ. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. Adv Drug Deliv Rev. 2009;61:1203–13.CrossRefPubMed Greco F, Vicent MJ. Combination therapy: opportunities and challenges for polymer-drug conjugates as anticancer nanomedicines. Adv Drug Deliv Rev. 2009;61:1203–13.CrossRefPubMed
13.
go back to reference Huang P, et al. Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy. J Am Chem Soc. 2014;136:11748–56.CrossRefPubMed Huang P, et al. Combination of small molecule prodrug and nanodrug delivery: amphiphilic drug-drug conjugate for cancer therapy. J Am Chem Soc. 2014;136:11748–56.CrossRefPubMed
16.
go back to reference Wentrup R, et al. Photodynamic therapy plus chemotherapy compared with photodynamic therapy alone in hilar Nonresectable cholangiocarcinoma. Gut Liver. 2016;10:470–5.CrossRefPubMedPubMedCentral Wentrup R, et al. Photodynamic therapy plus chemotherapy compared with photodynamic therapy alone in hilar Nonresectable cholangiocarcinoma. Gut Liver. 2016;10:470–5.CrossRefPubMedPubMedCentral
17.
18.
go back to reference Fan L, et al. Stimuli-free programmable drug release for combination chemo-therapy. Nano. 2016;8:12553–9. Fan L, et al. Stimuli-free programmable drug release for combination chemo-therapy. Nano. 2016;8:12553–9.
19.
go back to reference Fan L, et al. Multifunctional all-in-one drug delivery systems for tumor targeting and sequential release of three different anti-tumor drugs. Biomaterials. 2016;76:399–407.CrossRefPubMed Fan L, et al. Multifunctional all-in-one drug delivery systems for tumor targeting and sequential release of three different anti-tumor drugs. Biomaterials. 2016;76:399–407.CrossRefPubMed
20.
go back to reference Fernandez, E., et al., Modeling the squence-sensitive gemcitabine-docetaxel combination using the Virtual Tumor. AACR 102nd Annu. Meet. Orlando FL (2011). Fernandez, E., et al., Modeling the squence-sensitive gemcitabine-docetaxel combination using the Virtual Tumor. AACR 102nd Annu. Meet. Orlando FL (2011).
Metadata
Title
Ternary cocktail nanoparticles for sequential chemo-photodynamic therapy
Authors
Li Fan
Saisai Zhao
Qian Yang
Jiali Tan
Chaojun Song
Hong Wu
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Experimental & Clinical Cancer Research / Issue 1/2017
Electronic ISSN: 1756-9966
DOI
https://doi.org/10.1186/s13046-017-0586-1

Other articles of this Issue 1/2017

Journal of Experimental & Clinical Cancer Research 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine